Member Spotlight: Ryuichi Okomato, MD, PhD

Ryuichi Okomato, MD, PhD
Institute of Science Tokyo, Japan

Hometown
Tokyo, Japan

Current Residence
Chiba, Japan

Graduate Degree
MD, PhD

Current Position
Professor

ISSCR Participation
Speaker at the ISSCR 2025 Annual Meeting and Singapore International Symposium

  • Organoid-based therapy for inflammatory bowel disease. Engineering multi-layer intestinal tissue for transplantation.

  • We have launched a first-in-human clinical trial for autologous organoid transplantation for ulcerative colitis patients. It may be the first clinical use of somatic stem cell-derived organoids.

  • Gaining new results and evidence that may improve our organoid-based therapy or tissue engineering.

  • Curiosity and deep interest in stem cell based architecture of the human tissue.

  • The intestinal tissue has a simple but well-designed stem cell based system. Also, looking into the dynamic change in tissue regeneration environment may attract many trainees and researchers.

  • Not in particular.

  • Running along the riverside. Spending time with my family. Enjoying good food and sake.

  • Spent my childhood in London, UK.

  • Finding opportunities to collaborate with worldwide peers.

  • Learning new findings or techniques from other groups. Connecting with peers of other countries.

Previous
Previous

ISSCR Creates First-of-its Kind Continuing Education Course on Stem Cell-Based Medicine

Next
Next

Stem Cells Shed Insight Into Cardiovascular Disease Processes